ArticleBritish journal of clinical pharmacology2009

Use of pharmacokinetic/ pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics.

Balaji M AgoramPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.